MBX

Conviction 76HealthcareScan · Thu, Sep 24, 2026

MBX Biosciences, Inc. (MBX) closed at $55.32 (-4.44%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 34, RS Rating 97, -21.8% from its 52-week high, +81.1% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

MBX$55.32-4.44%

ResistanceSupportVol 14Insider sell

Vol MA14 588.05K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

MBX Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.mbxbio.com ↗

Price55.32

Change-4.44%

Gap-0.75%

Rel volume1.83×

Avg volume519.16K

Avg $ vol31.78M

SMA 2061.34

SMA 5063.60

SMA 20042.66

Price vs 50-13.02%

Price vs 200+29.67%

MA stackmixed

50/200 cross—

Supertrenddown · 65.75

RSI (14)34

MACD hist-0.55

MACD cross—

Stoch %K / %D8 / 21

ADX (14)20

+DI / −DI14 / 30

RSI divergence—

MACD divergenceBullish

ATR %5.86%

ADR %4.88%

52w high70.70

52w low13.22

From 52w high-21.75%

Above 52w low+318.46%

New 52w highNo

SqueezeOn · 3d

Bollinger width14.64%

%B-0.17

Donchian pos6.91%

Donchian high66.90

Donchian low54.46

AVWAP (52w high)63.70

vs AVWAP high-13.15%

AVWAP (52w low)39.01

vs AVWAP low+41.82%

OBV trendDown

Chaikin MF (20)-0.07

Today vs 20d1.83×

Avg vol (14d)588.05K

Avg vol (20d)519.16K

Avg $ vol (20d)31.78M

Market cap2.66B

RS Rating97 / 99

RS 3m (vs SPY)+5.34%

RS 6m (vs SPY)+74.20%

RS line new highNo

Trend template7/8

Technical rank62.8

1 week-13.41%

1 month-19.38%

3 months+9.83%

6 months+91.02%

1 year+191.77%

YTD+81.08%

P/E-30.63

P/B6.51

P/S—

P/FCF-32.54

EPS-2.38

Div yield—

ROE-21.24%

ROA-19.95%

Debt/Eq—

Current18.08

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-40.45%

Price target90.43

Target upside63.47%

Analyst ratingBuy

Institutional118.96%

Ent. value2.61B

Revenue—

Net income-37.09M

Gross profit—

Free cash flow-81.88M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out47.6M

Employees63

ListedFri, Sep 13, 2024

Free float28.64M

Float %60.2%

Short interest4.16M

Days to cover10.1d

Short volume48.9%

Squeeze score72 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.78 vs −$0.68

Last surprise-14.7% miss

Setup gradeA

Conviction76 / 100

Pattern quality—

Tech rank62.8 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance71.29

Support58.60

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jul 23 – Aug 3
5 scans
→
Breaking out now
Aug 4
1 scan
→
Broke out
Aug 5
1 scan
→
Retesting breakout
Aug 6
1 scan
→
Setting up
Aug 14 – Aug 17
2 scans

Congress activity

Disclosed STOCK Act trades in MBX

All disclosures →

No recent disclosed trades by Congress in MBX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MBX · open-market 1 sell

Insider	Side	Shares	Value	Traded	Filed
Azoulay Salomon Chief Medical Officer · Common Stock · 2026-08-04	Sell	370	$24K	2026-08-04	2026-08-05
Hoerter Steven L. Director · Stock option (right to buy) · 2026-06-04	Grant	12.5K	$0	2026-06-04	2026-06-05
Mathers Edward T Director · Stock option (right to buy) · 2026-06-04	Grant	12.5K	$0	2026-06-04	2026-06-05
Ryder Steven Director · Stock option (right to buy) · 2026-06-04	Grant	12.5K	$0	2026-06-04	2026-06-05
Hoerter Steven L. Director · Common Stock · 2026-06-04	Other	—	—	2026-06-04	2026-06-05
Pescovitz Ora H. Director · Common Stock · 2026-06-04	Other	—	—	2026-06-04	2026-06-05
Pescovitz Ora H. Director · Stock option (right to buy) · 2026-06-04	Grant	12.5K	$0	2026-06-04	2026-06-05
Stelzer Laurie Director · Stock option (right to buy) · 2026-06-04	Grant	12.5K	$0	2026-06-04	2026-06-05
Heron Patrick J Director · Stock option (right to buy) · 2026-06-04	Grant	12.5K	$0	2026-06-04	2026-06-05
Aynechi Tiba Director · Stock option (right to buy) · 2026-06-04	Grant	12.5K	$0	2026-06-04	2026-06-05

SEC filings

EDGAR filings in MBX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.